| Literature DB >> 28840624 |
Fernanda Guilhon-Simplicio1, Tallita Marques Machado1, Leandro Flores do Nascimento2, Rayanne da Silva Souza1, Hector Henrique Ferreira Koolen3, Felipe Moura Araújo da Silva4, Leonard Domingo Rosales Acho1, Adair Roberto Soares Dos Santos2, Paul Cos5, Maria de Meneses Pereira1, Emerson Silva Lima1.
Abstract
Species of the Byrsonima genus are widely used in Brazil, especially for the treatment of gastrointestinal disorders. However, species from the Amazonian region are still poorly studied. Thus, we studied the antioxidant, antinociceptive, and anti-inflammatory activities of for Amazonian species, Byrsonima crispa, Byrsonima duckeana, Byrsonima garcibarrigae, and Byrsonima incarnata. Phenolic composition was determined by chemical and chromatographic methods. The aqueous extracts were evaluated in DPPH• , ABTS+• , and superoxide (O2•- ) tests, LPS-activated macrophage assay, and formalin test. All species contained a high phenolic and flavonoid content. We identified 15 phenolic compounds, including phenolic acids, hydroxycinnamic acids, flavonoids, and catechins. The extracts showed high antioxidant activity and were more active than quercetin at inhibiting nitric oxide release in the LPS-activated macrophage assay. B. duckeana and B. garcibarrigae showed higher in vivo antinociceptive and anti-inflammatory activities. B. garcibarrigae presented significant effect on the early phase of the formalin test, pointing to an antinociceptive mechanism distinct from traditional anti-inflammatory medicines. In conclusion, the pharmacological potential of these species is closely related to their flavonoid-rich chemical composition, which seems to act through antioxidant mechanisms.Entities:
Keywords: Byrsonima; antinociceptive activity; antioxidant activity; flavonoids
Mesh:
Substances:
Year: 2017 PMID: 28840624 DOI: 10.1002/ptr.5884
Source DB: PubMed Journal: Phytother Res ISSN: 0951-418X Impact factor: 5.878